Teva Pharmaceutical Industries Limited (TLV:TEVA)

Market Cap	73.61B
Revenue (ttm)	61.87B
Net Income (ttm)	-4.79B
Shares Out	n/a
EPS (ttm)	-4.25
PE Ratio	n/a
Forward PE	7.05
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,234,908
Average Volume	3,273,103
Open	6,287.00
Previous Close	6,360.00
Day's Range	6,154.00 - 6,375.00
52-Week Range	4,865.00 - 8,431.00
Beta	0.63
RSI	59.97
Earnings Date	May 7, 2025

About TLV:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

In 2024, TLV:TEVA's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD